3096 First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses. (September 2015) - Gettinger, S.N.; Hellmann, M.D.; Shepherd, F.A.; Antonia, S.J.; Brahmer, J.; Chow, L.Q.; Goldman, J.; Juergens, R.; Borghaei, H.; Ready, N.E.; Gerber, D.E.; Nathan, F.; et al.